Baylor College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).

616 total trials 93 currently recruiting 376 completed early-phase tilt top decile by trial count

Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.

Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.

Top-decile sponsor footprint

Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 47/100

376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

616 total, page 5 of 13

COMPLETED Phase 3

Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)

NCT04371536

COMPLETED NA

Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder

NCT04922502

COMPLETED NA

BiZact Tonsillectomy in the Pediatric Population

NCT04725305

COMPLETED NA

Continuous Diffusion of Oxygen Treatment for Incision Wounds

NCT04307355

COMPLETED

ConMed Beamer Study

NCT04752670

COMPLETED

Hypotension in Children With Down Syndrome With Anesthesia Induction

NCT04603469

COMPLETED NA

Effectiveness of Healthy Habits for Hospitalized Older Adults to Optimize Rehabilitation

NCT04269239

COMPLETED Phase 1

L-Citrulline Dose Finding Safety Study in MELAS

NCT03952234

COMPLETED NA

Fit 24 Technology Intervention YOUTH

NCT04953442

COMPLETED

Prospective Study FNB, Is It Time To Abandon Cytological Assessment

NCT04165018

COMPLETED NA

Self-Administered Interactive Exercise Program (Tele-Exergame)

NCT07072962

COMPLETED

Transoral Incisionless Fundoplication in Post-POEM GERD

NCT04770441

COMPLETED NA

The i Heart Rhythm Project: Healthy Sleep and Behavioral Rhythms for Obesity Prevention

NCT04445740

COMPLETED

Food Insecurity Screening and Intervention: From Hospital to Home

NCT04739540

COMPLETED NA

Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')

NCT04481373

COMPLETED Early Phase 1

Transducer Selection in the Speed and Quality of Image Acquisition in FAST Exams

NCT04333680

COMPLETED Phase 1

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

NCT04345601

COMPLETED NA

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

NCT04784065

TERMINATED Early Phase 1

Ketamine in Veterans With Gulf War Illness

NCT04712071

TERMINATED Early Phase 1

Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19

NCT04703036

COMPLETED Phase 1

Electrical Stimulation for Critically Ill Covid-19 Patients

NCT04685213

COMPLETED NA

Home-Based Exercise to Treat Decreased Physical Function in Patients With Varying Levels of Kidney Function

NCT04745169

COMPLETED Phase 4

Alternate Day Versus Daily Oral Iron Therapy in Adolescents

NCT05007899

COMPLETED Phase 4

Ropivacaine Plasma Concentrations and Pharmacokinetics Following Erector Spinae Plane Block in the Pediatric Population

NCT04298099

TERMINATED NA

Endoscopic Strip Craniectomy for Treatment of Sagittal Craniosynostosis

NCT04721769

TERMINATED NA

A Distress Screening and Intervention in Cancer Surgery

NCT03979794

COMPLETED Phase 2

DiaBetter Together for Young Adults With Type 1 Diabetes

NCT04247620

COMPLETED NA

Marfan Syndrome Moderate Exercise Pilot

NCT04641325

TERMINATED Phase 1

Anti-SARS Cov-2 T Cell Infusions for COVID 19

NCT04401410

COMPLETED

Utility of OverStitch Sx After ESD

NCT04361227

COMPLETED NA

Prospective Evaluation of Self-Testing to Increase Screening

NCT03898167

COMPLETED Phase 4

Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder

NCT04188392

COMPLETED NA

Advancing Nutritional Science for Children With Functional Dyspepsia

NCT04053049

COMPLETED Phase 1

The Effectiveness of High Resolution Microendoscopy for People Living With HIV

NCT04563754

COMPLETED NA

Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD

NCT04111874

COMPLETED

Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea

NCT03938259

COMPLETED NA

Peer-led Group Intervention for Coping With Disaster

NCT03907995

COMPLETED NA

Feasibility Study of Family Teamwork Peer-Delivery

NCT04053504

COMPLETED Phase 3

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637

TERMINATED

Baylor Infant Biomarker of Nutrition Study

NCT03996395

COMPLETED Phase 1

Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)

NCT02905188

COMPLETED NA

Electrical Stimulation to Accelerate Wound Healing

NCT03821675

COMPLETED NA

Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety

NCT03720795

COMPLETED NA

Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population

NCT03134300

TERMINATED Phase 1

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

NCT03498196

COMPLETED Phase 1

NMDA Receptor Modulation for Hyperarousal in PTSD

NCT03166501

TERMINATED NA

On-Q Pump vs Epidural for Postoperative Pain Control in Children

NCT03496259

COMPLETED NA

Feasibility of Healthy Dads Healthy Kids Latino

NCT03532048

TERMINATED NA

Open Myelomeningocele Repair With High Maternal BMI

NCT03044821

COMPLETED Early Phase 1

Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)

NCT03568994

← Previous Page 5 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 173
Phase 2 59
Phase 3 13
Phase 4 46

What is open in the Baylor College of Medicine pipeline

93 recruiting of 616 indexed (15% open); 376 completed (61%).

Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor College of Medicine: open-pipeline peers nationwide

Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share Baylor College of MedicineUniversity of Southern CaliforniaUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentStanford UniversityBaylor UniversityCornell University59th Medical Wing
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 616 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Baylor College of Medicine page

616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.

  • 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.